From Spatial Epigenomes to Clinical Diagnostics: Integrative Methylomics Across Scales and Modalities
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27104377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Aiman Kinzhebay und 5 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Division, Cell and Gene Therapy Department, Qazaq Institute of Innovative Medicine, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: DNA Methylation, Epigenomics, Epigenome, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Methylomics has emerged as a central framework for understanding gene regulation in development and disease, yet the rapid expansion of profiling technologies, computational integration methods, and clinical applications has outpaced comprehensive synthesis. This review addresses that gap by systematically examining current advances across the full methylomics pipeline, from data generation to clinical translation. We draw on evidence from large-scale consortium datasets and benchmarking studies of multi-omics integration methods including MOFA, DIABLO, and deep learning architectures, single-cell and spatial methylomic technologies, long-read sequencing platforms (Oxford Nanopore, PacBio HiFi), and cell-free DNA (cfDNA) liquid biopsy approaches. The review further surveys methylation dysregulation across major disease domains, including cancer, cardiovascular disease, neurological disorders, and autoimmune conditions. Integrating methylomic data with transcriptomic and chromatin accessibility layers, particularly in spatial and single-cell contexts, substantially improves the resolution of disease-associated regulatory mechanisms. cfDNA methylation profiling emerges as a cross-disease, non-invasive monitoring platform with broad diagnostic potential, supported by machine learning-based deconvolution. We conclude that while technological barriers are diminishing, standardization of analytical workflows, population diversity in reference datasets, and regulatory alignment remain the principal challenges for translating methylomics advances into broadly accessible precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regenerative Medicine Division, Cell and Gene Therapy Department, Qazaq Institute of Innovative Medicine, Astana 010000, Kazakhstan.
- Department of Oncology, Astana Medical University, Astana 010000, Kazakhstan.
- Department of Computer Science, Al-Farabi Kazakh National University, Al-Farabi Avenue, Almaty 050040, Kazakhstan.
ORCID-Profile: Ainur Yerkos, Amankeldi A Salybekov
Förderung
- Ministry of Science and Higher Education of the Republic of Kazakhstan
- Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Kinzhebay, A., Zhanymbetova, A., Yerkos, A., Zhetpisbay, Z., Imanbek, R., & Salybekov, A. A. (2026). From Spatial Epigenomes to Clinical Diagnostics: Integrative Methylomics Across Scales and Modalities. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104377
Vancouver
Kinzhebay A, Zhanymbetova A, Yerkos A, Zhetpisbay Z, Imanbek R, Salybekov AA. From Spatial Epigenomes to Clinical Diagnostics: Integrative Methylomics Across Scales and Modalities. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27104377
BibTeX
@article{Kinzhebay2026,
author = {Kinzhebay, Aiman and Zhanymbetova, Aina and Yerkos, Ainur and Zhetpisbay, Zhibek and Imanbek, Rustem and Salybekov, Amankeldi A},
title = {From Spatial Epigenomes to Clinical Diagnostics: Integrative Methylomics Across Scales and Modalities},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27104377}
}
EUVIMED